Works by Sangfelt, Olle


Results: 22
    1

    PTENP1-AS contributes to BRAF inhibitor resistance and is associated with adverse clinical outcome in stage III melanoma.

    Published in:
    Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-89389-9
    By:
    • Vidarsdottir, Linda;
    • Azimi, Alireza;
    • Das, Ishani;
    • Sigvaldadottir, Ingibjorg;
    • Suryo Rahmanto, Aldwin;
    • Petri, Andreas;
    • Kauppinen, Sakari;
    • Ingvar, Christian;
    • Jönsson, Göran;
    • Olsson, Håkan;
    • Frostvik Stolt, Marianne;
    • Tuominen, Rainer;
    • Sangfelt, Olle;
    • Pokrovskaja Tamm, Katja;
    • Hansson, Johan;
    • Grandér, Dan;
    • Egyházi Brage, Suzanne;
    • Johnsson, Per
    Publication type:
    Article
    2
    3

    Single cell characterization of B-lymphoid differentiation and leukemic cell states during chemotherapy in ETV6-RUNX1-positive pediatric leukemia identifies drug-targetable transcription factor activities.

    Published in:
    Genome Medicine, 2020, v. 12, n. 1, p. N.PAG, doi. 10.1186/s13073-020-00799-2
    By:
    • Mehtonen, Juha;
    • Teppo, Susanna;
    • Lahnalampi, Mari;
    • Kokko, Aleksi;
    • Kaukonen, Riina;
    • Oksa, Laura;
    • Bouvy-Liivrand, Maria;
    • Malyukova, Alena;
    • Mäkinen, Artturi;
    • Laukkanen, Saara;
    • Mäkinen, Petri I.;
    • Rounioja, Samuli;
    • Ruusuvuori, Pekka;
    • Sangfelt, Olle;
    • Lund, Riikka;
    • Lönnberg, Tapio;
    • Lohi, Olli;
    • Heinäniemi, Merja
    Publication type:
    Article
    4

    FBW7 suppression leads to SOX9 stabilization and increased malignancy in medulloblastoma.

    Published in:
    EMBO Journal, 2016, v. 35, n. 20, p. 2192, doi. 10.15252/embj.201693889
    By:
    • Suryo Rahmanto, Aldwin;
    • Savov, Vasil;
    • Brunner, Andrä;
    • Bolin, Sara;
    • Weishaupt, Holger;
    • Malyukova, Alena;
    • Rosén, Gabriela;
    • Čančer, Matko;
    • Hutter, Sonja;
    • Sundström, Anders;
    • Kawauchi, Daisuke;
    • Jones, David TW;
    • Spruck, Charles;
    • Taylor, Michael D;
    • Cho, Yoon‐Jae;
    • Pfister, Stefan M;
    • Kool, Marcel;
    • Korshunov, Andrey;
    • Swartling, Fredrik J;
    • Sangfelt, Olle
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12
    13

    TRIM13 ( RFP2) downregulation decreases tumour cell growth in multiple myeloma through inhibition of NF Kappa B pathway and proteasome activity.

    Published in:
    British Journal of Haematology, 2013, v. 162, n. 2, p. 210, doi. 10.1111/bjh.12365
    By:
    • Gatt, Moshe E.;
    • Takada, Kohichi;
    • Mani, Mala;
    • Lerner, Mikael;
    • Pick, Marjorie;
    • Hideshima, Teru;
    • Carrasco, Daniel E.;
    • Protopopov, Alexei;
    • Ivanova, Elena;
    • Sangfelt, Olle;
    • Grandér, Dan;
    • Barlogie, Bart;
    • Shaughnessy, John D.;
    • Anderson, Kenneth C.;
    • Carrasco, Daniel R.
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20
    21
    22